Novartis Pays $25M To SEC In Chinese FCPA Case

By Carmen Germaine · March 23, 2016, 5:03 PM EDT

Novartis AG will pay a $2 million penalty and $23 million in disgorgement and interest to settle U.S. Securities and Exchange Commission allegations that Chinese subsidiaries violated the Foreign Corrupt Practices...

To view the full article, register now.